Genmab ADR (NASDAQ: GMAB) Recovers 15.33% From 52-Week Low, Is GMAB Still A High-Risk, High-Reward Play?

Genmab ADR (NASDAQ:GMAB) currently has a daily average trading volume of 588.59K but it saw 701995 shares traded in last market. With a market cap of 18.43B USD, the company’s current market price of $28.29 came rising about 0.28 while comparing to the previous closing price of $28.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $41.58 and as low as $24.53.

Taking a look at 20-day trading activity of Genmab ADR (GMAB) gives us an average price of $27.06, while its current price level is -31.96% below from 52-week high level whereas it is 15.33% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $27.15 while that of 200 days or SMA-200 reads an average of $29.18. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.43% during that period while stretching the period over a month that decreases to 1.37%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 64.86 which implies that the stock is in neutral territory.

BMO Capital Markets upgraded its recommendation for the stock as a “Outperform” from “Market Perform” on February 23, 2024 while assigning a price target range of $46-$48.

Over the week, GMAB’s stock price is moving 1.47% up while it is 13.84% when we observe its performance for the past one month. Year-to-date it is -11.15% down and over the past year, the stock is showing a downside performance of -31.60%.

Currently, Genmab ADR’s total number of outstanding shares is 653.30M. Company’s return on investment (ROI) stands at 16.41% and return on equity (ROE) at 18.32%. It has a price to earnings ratio (P/E ratio) of 23.46 while having a 19.40 of forward P/E ratio. Stock’s beta reads 0.95. Stock has a price to book (P/B) ratio of 3.92 while price to sale or P/S ratio amounts to 7.14. Its return on asset (ROA) is 16.30% on average.